Introduction —
This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Juvenile idiopathic arthritis" and "Society guideline links: Psoriasis" and "Society guideline links: Spondyloarthritis".)
International
●Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): Updated treatment recommendations for psoriatic arthritis, 2021 (published 2022)
Canada
●CRA/SPARCC: Treatment recommendations for the management of spondyloarthritis – Part II: Specific management recommendations, 2014 update (published 2015)
United States
●American College of Rheumatology (ACR)/NPF: Guideline for the treatment of psoriatic arthritis (2018)
Europe
●European League Against Rheumatism (EULAR): Recommendations for the management of psoriatic arthritis with pharmacological therapies, 2023 update (published 2024)
United Kingdom
Japan
●[In Japanese] Japanese Dermatological Association (JDA): Psoriatic arthritis practice guidelines (2019)